Real-time PCR for Chlamydia pneumoniae utilizing the Roche Lightcycler and a 16S rRNA gene target
Justin Hardick1, Nancy Maldeis, Mellisa Theodore
1Johns Hopkins University, School of Medicine, Baltimore, Maryland, USA.
Abstract:
Chlamydia pneumoniae (CPN) causes pneumonia in humans, and has emerged as an important respiratory pathogen. There are also established links between CPN infection and coronary artery disease. Traditional culture methods for CPN detection can be time consuming and difficult. There are a variety of molecular-based amplification methods for CPN detection. These methods are more sensitive than culture, but have the disadvantage of being inconsistent and non-comparable across studies. In this paper, we describe the adaptation of the existing primer set CPN 90/CPN91 for use in a real-time PCR assay using the Roche Lightcycler and a Taqman probe. This assay had an analytical sensitivity of between 4 and 0.4 infection-forming units (IFUs)/PCR reaction. A total of 355 samples were tested for validation of the assay. Tested samples included two standardized panels of blinded samples from culture (N = 70), archived specimens consisting of a CPN dilution series, CPN-spiked porcine aortal tissue and endarterectomy specimens (N = 87). The third group consisted of prospectively collected PBMCs from clinical samples (N = 198). Results were compared to nested PCR, which targets the ompA gene of CPN; TETR PCR, which targets the 16S rRNA gene of CPN; or the known result for the sample. Overall, the assay had a sensitivity of 88.5% (69 of 78) and a specificity of 99.3% (275 of 277). This method should prove useful for accurate, high throughput detection of CPN.
Insights
A new real-time PCR assay accurately detects Chlamydia pneumoniae (CPN), a pathogen linked to pneumonia and heart disease. This method offers a sensitive and specific alternative to traditional culture and inconsistent molecular tests.
Area of Science:
- Microbiology
- Molecular Biology
- Infectious Diseases
Background:
- Chlamydia pneumoniae (CPN) is a significant respiratory pathogen associated with pneumonia and coronary artery disease.
- Traditional CPN detection methods, such as culture, are time-consuming and labor-intensive.
- Existing molecular detection methods for CPN lack consistency and comparability across studies.
Purpose of the Study:
- To adapt an existing primer set (CPN 90/CPN91) for a real-time PCR assay.
- To develop a sensitive, specific, and high-throughput method for CPN detection.
- To validate the real-time PCR assay using diverse sample types.
Main Methods:
- Development of a real-time PCR assay utilizing the Roche Lightcycler and a Taqman probe with the CPN 90/CPN91 primer set.
- Analytical sensitivity testing determined to be between 4 and 0.4 infection-forming units (IFUs)/PCR reaction.
- Validation using 355 samples, including standardized blinded panels, archived specimens (dilution series, spiked tissues), and prospective clinical samples (PBMCs).
Main Results:
- The real-time PCR assay demonstrated high analytical sensitivity.
- Validation against nested PCR (ompA gene) and TETR PCR (16S rRNA gene) showed an overall sensitivity of 88.5% and specificity of 99.3%.
- The assay performed consistently across various sample types, including clinical specimens.
Conclusions:
- The developed real-time PCR assay provides accurate and reliable detection of Chlamydia pneumoniae.
- This method offers a valuable tool for high-throughput screening and diagnosis of CPN infections.
- The assay's sensitivity and specificity make it a promising alternative to conventional detection techniques.
